Susquehanna International Group’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $27.4M | Sell |
634,573
-105,131
| -14% | -$4.54M | ﹤0.01% | 334 |
|
|
2025
Q1 | $25.6M | Sell |
739,704
-484,578
| -40% | -$16.8M | ﹤0.01% | 291 |
|
|
2024
Q4 | $33.6M | Buy |
1,224,282
+509,125
| +71% | +$14M | 0.01% | 284 |
|
|
2024
Q3 | $18.2M | Buy |
715,157
+38,508
| +6% | +$980K | ﹤0.01% | 403 |
|
|
2024
Q2 | $17.1M | Buy |
676,649
+618,296
| +1,060% | +$15.7M | ﹤0.01% | 446 |
|
|
2024
Q1 | $1.8M | Sell |
58,353
-43,962
| -43% | -$1.36M | ﹤0.01% | 1948 |
|
|
2023
Q4 | $4.13M | Sell |
102,315
-305,338
| -75% | -$12.3M | ﹤0.01% | 1299 |
|
|
2023
Q3 | $10.7M | Buy |
407,653
+14,292
| +4% | +$377K | ﹤0.01% | 673 |
|
|
2023
Q2 | $6.77M | Sell |
393,361
-131,947
| -25% | -$2.27M | ﹤0.01% | 922 |
|
|
2023
Q1 | $8.71M | Buy |
525,308
+447,691
| +577% | +$7.42M | ﹤0.01% | 806 |
|
|
2022
Q4 | $591K | Sell |
77,617
-180,426
| -70% | -$1.37M | ﹤0.01% | 2969 |
|
|
2022
Q3 | $2.57M | Buy |
258,043
+208,650
| +422% | +$2.07M | ﹤0.01% | 1418 |
|
|
2022
Q2 | $448K | Sell |
49,393
-123,304
| -71% | -$1.12M | ﹤0.01% | 3493 |
|
|
2022
Q1 | $1.75M | Sell |
172,697
-233,634
| -57% | -$2.37M | ﹤0.01% | 2162 |
|
|
2021
Q4 | $6.78M | Buy |
406,331
+355,718
| +703% | +$5.93M | ﹤0.01% | 994 |
|
|
2021
Q3 | $2.37M | Buy |
50,613
+30,957
| +157% | +$1.45M | ﹤0.01% | 1788 |
|
|
2021
Q2 | $1.2M | Buy |
19,656
+13,387
| +214% | +$816K | ﹤0.01% | 2737 |
|
|
2021
Q1 | $386K | Sell |
6,269
-11,780
| -65% | -$725K | ﹤0.01% | 4114 |
|
|
2020
Q4 | $1.28M | Sell |
18,049
-2,255
| -11% | -$160K | ﹤0.01% | 2240 |
|
|
2020
Q3 | $761K | Sell |
20,304
-7,971
| -28% | -$299K | ﹤0.01% | 2568 |
|
|
2020
Q2 | $922K | Sell |
28,275
-16,930
| -37% | -$552K | ﹤0.01% | 2253 |
|
|
2020
Q1 | $1.31M | Buy |
+45,205
| New | +$1.31M | ﹤0.01% | 1704 |
|
|
2019
Q4 | – | Sell |
-10,078
| Closed | -$216K | – | 4018 |
|
|
2019
Q3 | $216K | Buy |
+10,078
| New | +$216K | ﹤0.01% | 3775 |
|